A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Completed · Phase 3

Conditions studied: Rhinitis, Allergic, Perennial

In brief

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).

Key facts

Study ID

NCT00103454

Run by

GlaxoSmithKline

People needed

288

Starts

2005-01-01

Expected to finish

2005-05-01

Last updated by the study team

2016-09-19

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of perennial allergic rhinitis (PAR).
• Must comply with study procedures and be literate.

You may not qualify if…

• Significant concomitant medical conditions.
• Use of corticosteroids.
• Use of allergy medications and some other medications during the study.
• Current tobacco use.
• Clinically significant abnormal ECG or laboratory abnormality.

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Mission Viejo, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Tallahassee, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Vero Beach, Florida, United States
• GSK Investigational Site — Lawrenceville, Georgia, United States
• GSK Investigational Site — Lilburn, Georgia, United States
• GSK Investigational Site — South Bend, Indiana, United States
• GSK Investigational Site — Metairie, Louisiana, United States
• GSK Investigational Site — Portland, Maine, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — North Andover, Massachusetts, United States
• GSK Investigational Site — North Dartmouth, Massachusetts, United States
• GSK Investigational Site — Springfield, Massachusetts, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.